Bank of America’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-44,317
| Closed | -$406K | – | 8649 |
|
|
2021
Q2 | $406K | Buy |
44,317
+10,342
| +30% | +$60.2K | ﹤0.01% | 5581 |
|
|
2021
Q1 | $169K | Buy |
33,975
+16,126
| +90% | +$77.9K | ﹤0.01% | 6141 |
|
|
2020
Q4 | $77K | Buy |
17,849
+8,224
| +85% | +$33.5K | ﹤0.01% | 6121 |
|
|
2020
Q3 | $41K | Sell |
9,625
-6,804
| -41% | -$28.4K | ﹤0.01% | 6092 |
|
|
2020
Q2 | $74K | Buy |
16,429
+2,104
| +15% | +$9.4K | ﹤0.01% | 5814 |
|
|
2020
Q1 | $57K | Sell |
14,325
-3,041
| -18% | -$25.8K | ﹤0.01% | 5821 |
|
|
2019
Q4 | $147K | Buy |
17,366
+1,217
| +8% | +$9.5K | ﹤0.01% | 5806 |
|
|
2019
Q3 | $111K | Buy |
16,149
+2,206
| +16% | +$16.2K | ﹤0.01% | 6002 |
|
|
2019
Q2 | $115K | Sell |
13,943
-31
| -0.2% | -$267 | ﹤0.01% | 5936 |
|
|
2019
Q1 | $128K | Sell |
13,974
-31,553
| -69% | -$320K | ﹤0.01% | 5743 |
|
|
2018
Q4 | $498K | Sell |
45,527
-12,243
| -21% | -$154K | ﹤0.01% | 4932 |
|
|
2018
Q3 | $806K | Buy |
57,770
+28,310
| +96% | +$383K | ﹤0.01% | 4624 |
|
|
2018
Q2 | $314K | Buy |
29,460
+6,860
| +30% | +$66.9K | ﹤0.01% | 5162 |
|
|
2018
Q1 | $195K | Sell |
22,600
-1,560
| -6% | -$13.7K | ﹤0.01% | 5382 |
|
|
2017
Q4 | $228K | Buy |
24,160
+2,663
| +12% | +$20.8K | ﹤0.01% | 5345 |
|
|
2017
Q3 | $168K | Buy |
21,497
+1,182
| +6% | +$8.87K | ﹤0.01% | 5466 |
|
|
2017
Q2 | $175K | Sell |
20,315
-72,158
| -78% | -$518K | ﹤0.01% | 5373 |
|
|
2017
Q1 | $652K | Sell |
92,473
-10,001
| -10% | -$62.7K | ﹤0.01% | 4710 |
|
|
2016
Q4 | $436K | Sell |
102,474
-847
| -0.8% | -$4.1K | ﹤0.01% | 4892 |
|
|
2016
Q3 | $515K | Sell |
103,321
-688
| -0.7% | -$2.91K | ﹤0.01% | 4605 |
|
|
2016
Q2 | $368K | Buy |
104,009
+3,532
| +4% | +$13K | ﹤0.01% | 4858 |
|
|
2016
Q1 | $347K | Buy |
100,477
+20,701
| +26% | +$73.1K | ﹤0.01% | 4834 |
|
|
2015
Q4 | $271K | Buy |
79,776
+3,761
| +5% | +$17.4K | ﹤0.01% | 5187 |
|
|
2015
Q3 | $396K | Sell |
76,015
-304
| -0.4% | -$1.87K | ﹤0.01% | 4957 |
|
|
2015
Q2 | $520K | Buy |
76,319
+275
| +0.4% | +$1.95K | ﹤0.01% | 4669 |
|
|
2015
Q1 | $542K | Buy |
76,044
+5,529
| +8% | +$38.1K | ﹤0.01% | 4258 |
|
|
2014
Q4 | $525K | Buy |
70,515
+57,615
| +447% | +$489K | ﹤0.01% | 4590 |
|
|
2014
Q3 | $119K | Buy |
12,900
+11,587
| +882% | +$157K | ﹤0.01% | 5856 |
|
|
2014
Q2 | $24K | Buy |
+1,313
| New | +$22.3K | ﹤0.01% | 7094 |
|
Other funds holding KIN
Bank of America's KIN Position: Q3 2021 in Review
Bank of America sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 44,317 shares — an estimated $406K sold.
Bank of America first reported a position in KIN in Q2 2014 and held it in 29 quarters. The position peaked at $806K in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Bank of America reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Bank of America sold 44,317 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $406K.
- Bank of America first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 29 quarters.
- Bank of America's Kindred Biosciences, Inc. position peaked at $806K in Q3 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Bank of America's 13F filing for Q3 2021, filed 15 Nov 2021.